A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19.
Clinical trial NCT05386420 · UNKNOWN
Trial details
- NCT number
- NCT05386420
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-23
- Primary completion
- 2022-08-15
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.